These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8727595)

  • 1. Is the Nef protein of HIV-1 required for pathogenesis?
    Miller MD; Greene WC
    Trends Microbiol; 1996 May; 4(5):171-2; discussion 173. PubMed ID: 8727595
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
    Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
    Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nef and the Nef-associated kinase.
    Sawai ET; Cheng-Mayer C; Luciw PA
    Res Virol; 1997; 148(1):47-52. PubMed ID: 9017834
    [No Abstract]   [Full Text] [Related]  

  • 5. Nef and PAK: virulence factor and cellular accomplice.
    Trono D; Wang JK
    Chem Biol; 1997 Jan; 4(1):13-5. PubMed ID: 9070423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.
    Sawai ET; Hamza MS; Ye M; Shaw KE; Luciw PA
    J Virol; 2000 Feb; 74(4):2038-45. PubMed ID: 10644378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS. The positive effect of the negative factor.
    Cullen BR
    Nature; 1991 Jun; 351(6329):698-9. PubMed ID: 1829506
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines based on Nef and on Nef/DeltaV2 Env.
    Erfle V; Goebel FD; Guzman CA; Le Grand R
    Microbes Infect; 2005 Nov; 7(14):1400-4. PubMed ID: 16243564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.
    Kirchhoff F; Schindler M; Bailer N; Renkema GH; Saksela K; Knoop V; Müller-Trutwin MC; Santiago ML; Bibollet-Ruche F; Dittmar MT; Heeney JL; Hahn BH; Münch J
    J Virol; 2004 Jul; 78(13):6864-74. PubMed ID: 15194762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
    Baba TW; Jeong YS; Pennick D; Bronson R; Greene MF; Ruprecht RM
    Science; 1995 Mar; 267(5205):1820-5. PubMed ID: 7892606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.
    Silverstein PS; Mackay GA; Mukherjee S; Li Z; Piatak M; Lifson JD; Narayan O; Kumar A
    J Virol; 2000 Nov; 74(22):10489-97. PubMed ID: 11044093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs.
    Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M
    Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/SIV escape from immune surveillance: focus on Nef.
    Tolstrup M; Ostergaard L; Laursen AL; Pedersen SF; Duch M
    Curr HIV Res; 2004 Apr; 2(2):141-51. PubMed ID: 15078178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid size dependent deletion of foreign gene sequences inserted into attenuated HIV-1 upon infection in vivo: implications for vaccine development.
    Brooks DG; Cohen MD; Jamieson BD; Poon B; Kitchen SG; Chow SA; Chen IS; Zack JA; Koka PS
    Curr HIV Res; 2005 Oct; 3(4):377-92. PubMed ID: 16250884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates.
    Waterman PM; Kitabwalla M; Hatfield GS; Evans PS; Lu Y; Tikhonov I; Bryant JL; Pauza CD
    Viral Immunol; 2004; 17(4):545-57. PubMed ID: 15671751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
    Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
    J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.